🇺🇸 FDA
Patent

US 8598316

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

granted A61KA61K31/00A61K47/62

Quick answer

US patent 8598316 (Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies) held by The Regents of the University of California expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K31/00, A61K47/62, A61K49/0043, A61K49/0056